Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic
Completed · Not applicable
Conditions studied: Mild Cognitive Impairment
In brief
This study will evaluate the therapeutic efficacy of Neuro-World cognitive training games (Woorisoft, S. Korea) in patients with mild cognitive impairment.
Key facts
- Study ID
- NCT04920123
- Run by
- University of Massachusetts, Amherst
- People needed
- 19
- Starts
- 2022-02-17
- Expected to finish
- 2025-03-31
- Last updated by the study team
- 2025-08-07
Who can join
Age: 55 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Seventeen points or greater and smaller than twenty-six points on the Montreal Cognitive Assessment (MoCA)
- Fifty-five years old and above
- Minimal technological literacy (i.e. ability to use a tablet independently)
- Having a computer for online videoconferencing-based communication (necessary for online cognitive assessments)
You may not qualify if…
- Confounding neurological and psychiatric disorders
- History of traumatic brain injury
- Clinically known hearing or vision impairment
- Severe upper-limb motor impairments that could impact the use of mobile devices
- Clinical presentations suggestive of dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, or vascular parkinsonism
- Diagnosis of dementia
- Major depression
- Any significant upper-limb impairment that could affect tablet use
- Participation in any other therapist-supervised cognitive training
Where it is running
- University of Massachusetts, Amherst — Amherst, Massachusetts, United States
- The State University of New Jersey, Rutgers — Newark, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.